BACE1 was also studied as a potential therapeutic target, with the studies on AD mouse models being worth mentioning, where the deficiency of BACE1 was correlated with an important reduction in Aβ40/42 levels, reduced neuronal loss, and memory deficits [44]. This evidence concerns the gene BACE1 and Alzheimer disease.